Medical/Pharmaceuticals
Innovent Announces the First Patient Dosed in the Phase I/II Study of IBI351 (KRAS G12C inhibitor) in Patients with Advanced Malignant Tumors
SAN FRANCISCO and SUZHOU, China, Sept. 30, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...
2021-09-30 08:00
2818
ObvioHealth Partners with Anatara Lifesciences to Launch First-of-its-kind Decentralized Clinical Trial in Australia
NEW YORK, Sept. 30, 2021 /PRNewswire/ -- ObvioHealth, a global Virtual Research Organization (VRO), today announces the launch of a first-of-its kind clinical trial inAustralia, using a combination of in-home data collection methods that will reduce, and in some cases, eliminate the need for fo...
2021-09-30 07:00
1220
SHOW JIANGSU Media Tour visit Jiangsu Suyun Medical Materials in Lianyungang
LIANYUNGANG, China, Sept. 29, 2021 /PRNewswire/ -- On 18 September 2021, SHOW JIANGSU Media Tour was held in Lianyungang, Jiangsu province. Jiangsu Suyun Medical Materials Co.,Ltd is a medical material supplier that produces blood-infusion sets, tubes, catheter and other medical equipment, accord...
2021-09-29 22:43
1387
Nanoform receives funding to solve challenges for global health
HELSINKI, Sept. 29, 2021 /PRNewswire/ -- Nanoform, an innovative nanoparticle medicine enabling company, announces that Proof of Concept studies will be funded by the Bill & Melinda Gates Foundation to assess the added value Nanoform's award-winning CESS® nanoparticle engineering technology can d...
2021-09-29 21:15
1698
New Accedian Research Finds 76% of Manufacturers Plan to Use Private 5G by 2024
MONTREAL, Canada, Sept. 29, 2021 /PRNewswire/ -- Accedian, a leader in performance analytics, cybersecurity threat detection and end user experience solutions, today released new analyst research on the future of 5G in manufacturing. Conducted in partnership with Analysys Mason, a leading manage...
2021-09-29 21:07
1737
Recbio and Rhegen Signed an mRNA Vaccine Cooperation Agreement
TAIZHOU, China, Sept. 29, 2021 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (referred to as "Recbio") and Shenzhen Rhegen Biotechnology Co., Ltd. (referred to as "Rhegen Bio") recently signed a joint venture agreement to establish a joint venture company "Wuhan Rhecogen Biotechnology Co., ...
2021-09-29 19:37
2313
Everest Medicines Initiates Submission of New Drug Application in Hong Kong for XeravaTM for the Treatment of Complicated Intra-abdominal Infections
SHANGHAI, Sept. 29, 2021 /PRNewswire/ -- Everest Medicines
2021-09-29 17:44
2536
MiZ Company Limited Publishes Review Article on Discovery of Diatomic Molecule That Overcomes Diseases Caused by Chronic Inflammation, Incurable by Modern Medicine
KAMAKURA, Japan, Sept. 29, 2021 /PRNewswire/ -- - Parkinson's Disease, Viral Pneumonia, Pancreatic Cancer, Chronic Kidney Disease, Artificial Dialysis - A paper titled "The overlooked benefits of hydrogen-producing bacteria. -Super beneficial Bacteria-," submitted by MiZ Company Limited (MiZ Co...
2021-09-29 15:00
1100
Molecular Stethoscope, Inc. Announces Presentation at 16th Annual Sequencing to Function: Analysis and Applications for the Future Meeting
Presentation highlights a path forward to lead the development of the Company's clinical-grade Next-Generation cf-mRNA Liquid Biopsy-Artificial Intelligence Technology Platform PALO ALTO, Calif., Sept. 29, 2021 /PRNewswire/ -- Molecular Stethoscope, Inc., a Precision Medicine biotechnology compa...
2021-09-29 15:00
1417
Zhaoke Ophthalmology's IND Application for Potential First Myopia Drug to Market in China and Globally, NVK-002, Approved for Phase III Clinical Trial by the CDE
* Targets broadest patient group – three to 17 years old * Two concurrent clinical trials, one leveraging global study to accelerate time to market * Phase III clinical trials testing two different doses to tailor for individual patients HONG KONG, Sept. 29, 2021 /PRNewswire/ -- Zhaoke Opht...
2021-09-29 12:17
4112
ClearMask introduces world's first CE-marked, fully transparent surgical mask
Fully transparent, anti-fog masks available in the European Union to provide clear communication and safety for healthcare providers and essential workers BALTIMORE, Sept. 29, 2021 /PRNewswire/ -- ClearMask LLC, a privately held American medical supply company, announced today that its ClearMask™...
2021-09-29 09:00
1953
Sinocare Showcases Diabetes and Chronic Diseases Management Products at the Second China-Africa Economic and Trade Expo
CHANGSHA, China, Sept. 29, 2021 /PRNewswire/ -- Sinocare, the global leading medical test-developer, has showcased its latest lineup of products at The Second China-Africa Economic and Trade Expo (CAETE), which was held between September 26-29 at the Changsha International Convention and Exhibitio...
2021-09-29 08:03
1229
Innovent Releases Preliminary Results of the Phase Ia Dose-Escalation study of IBI315 (Anti-Her2/PD-1 Bispecific Antibody) in Patients with Advanced Solid Tumors at CSCO Annual Meeting 2021
SAN FRANCISCO and SUZHOU, China, Sept. 29, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...
2021-09-29 08:00
2803
Lifebit raises $60m to make vital biomedical data securely accessible for life changing research worldwide
LONDON, Sept. 29, 2021 /PRNewswire/ -- Lifebit Biotech Ltd – the leading precision medicine software company democratising access to biomedical data for governments, healthcare providers and research teams worldwide – has raised a $60 million Series B funding round, led by global investment firm T...
2021-09-29 08:00
3388
MetaCell launches innovative Cloud Hosting for life science and healthcare
CAMBRIDGE, Mass., Sept. 29, 2021 /PRNewswire/ -- MetaCell, an innovative life
science software company specialized in creating cutting-edge research software
for major pharma, biotech, and academic institutions, has launchedMetaCell
Cloud Hosting
2021-09-29 07:54
1728
Heart Experts Call For Millions To Benefit From Life-Saving Online Services As Telemedicine Rockets
- Cardiovascular disease (CVD) remains world's biggest killer, claiming 18.6 million lives per year GENEVA, Sept. 29, 2021 /PRNewswire/ -- On World Heart Day, 29 September 2021, the World Heart Federation (WHF) is calling on the international community to bring digital cardiovascular health ser...
2021-09-29 07:49
1253
EW Nutrition launches Pretect D to support poultry gut health during challenging periods
VISBEK, Germany, Sept. 29, 2021 /PRNewswire/ -- EW Nutrition announces the launch of a novel gut health solution for poultry. Pretect D, a proprietary blend of phytomolecules, helps maintain bird performance and farm profitability. Trials indicate that Pretect D offers natural support even during...
2021-09-29 07:40
1025
VISTA Eye Specialist (VISTA), wins 2020 Best Customer Service Award from The Star Outstanding Business Awards (SOBA)
PETALING JAYA, Malaysia, Sept. 28, 2021 /PRNewswire/ -- One of the leading eye specialists inMalaysia, VISTA has been named the winner for Best Customer Service by The SOBA 2020 awards. Chosen amongst hundreds of nominations, the annual awards highlight the nation's best up-and-coming local, smal...
2021-09-28 20:30
2492
I-Mab Announces Acceptance of IND Application from China NMPA for Phase 2 Clinical Trial of Enoblituzumab in Combination with Pembrolizumab in Solid Tumors
SHANGHAI and GAITHERSBURG, Md., Sept. 28, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the Center for Drug Evaluation (CDE) of China Nati...
2021-09-28 20:00
3629
BioVaxys Begins Toxicity Study Ahead of CoviDTH IND Submission
VANCOUVER, BC, Sept. 28, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF)("BioVaxys" or "Company"), announced today that it has started its plannedin vivo animal toxicology study of CoviDTH in parallel with the preparation of an IND submission. Under the terms ...
2021-09-28 20:00
5959
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 290 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 289 media titles]
2024-04-22 06:00
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 287 media titles]
2024-04-18 21:26
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25
Animated Life in Yunnan
[Picked up by 281 media titles]
2024-04-18 14:00
Most Read
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
2024-04-18 21:26
8102
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
8049
Animated Life in Yunnan
2024-04-18 14:00
7784
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
6465
IQAX eBL Wins Prestigious APTFF Trade Facilitation Innovation Award 2024
2024-04-18 10:36
3871